{
    "clinical_study": {
        "@rank": "132639", 
        "acronym": "PROVAR", 
        "arm_group": [
            {
                "arm_group_label": "Variable Ventilation", 
                "arm_group_type": "Active Comparator", 
                "description": "Variable tidal volumes with mean at 8 mL/kg of predicted body weight"
            }, 
            {
                "arm_group_label": "Non-variable Ventilation", 
                "arm_group_type": "No Intervention", 
                "description": "Conventional mechanical ventilation with tidal volume 8 mL/kg of predicted body weight"
            }
        ], 
        "brief_summary": {
            "textblock": "Variable ventilation has been shown to improve lung function and reduce lung damage as well\n      as inflammation in different models of the acute respiratory distress syndrome. Also,\n      variable ventilation is able to recruit lungs. The present study will investigate whether\n      variable as compared to non-variable ventilation improves post-operative lung function and\n      reduces systemic inflammation in patients submitted to open abdominal surgery."
        }, 
        "brief_title": "Protective Variable Ventilation for Open Abdominal Surgery", 
        "condition": "Development of Pulmonary Dysfunction Following Open Abdominal Surgery", 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  elective open abdominal surgery\n\n          -  ASA classification 2-3\n\n          -  age between 18 und 85 yrs\n\n          -  expected duration of surgery > 3 h\n\n          -  expected extubation in the operation room\n\n          -  written informed consent\n\n        Exclusion Criteria:\n\n          -  chronic lung disease (except to COPD stadium I and II, and asthma)\n\n          -  Body Mass Index (BMI) > 40\n\n          -  allergy to one of the drugs to be used for general anesthesia\n\n          -  participation in another interventional trial within 4 weeks before enrollment\n\n          -  addiction or any other disease that may interfere with the capacity of giving\n             informed consent\n\n          -  pregnant or breastfeeding women\n\n          -  women in reproductive age, except to those who fulfill one of the following:\n\n               -  post-menopause (12 months natural amenorrhoea, or 6 months amenorrhoea and serum\n                  FSH > 40 mlU/ml\n\n               -  post-operative (6 weeks after two-sided ovariectomy)\n\n               -  routine and correct use of anticonceptional methods with failure rate < 1 % per\n                  year\n\n               -  sexually not active\n\n               -  vasectomy of the partner\n\n          -  indication of low compliance with the protocol\n\n          -  contraindication for MRI examination"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01683578", 
            "org_study_id": "PulmEngineering-2012-01"
        }, 
        "intervention": {
            "arm_group_label": "Variable Ventilation", 
            "intervention_name": "Variable Ventilation", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "mechanical ventilation", 
            "lung function", 
            "abdominal surgery, open", 
            "systemic inflammation"
        ], 
        "lastchanged_date": "September 10, 2012", 
        "link": {
            "description": "Homepage of the Pulmonary Engineering Group Dresden", 
            "url": "http://www.peg-dresden.de"
        }, 
        "location": {
            "contact": {
                "email": "mgabreu@uniklinikum-dresden.de", 
                "last_name": "Marcelo Gama de Abreu, MD, PhD", 
                "phone": "+493514584488"
            }, 
            "facility": {
                "address": {
                    "city": "Dresden", 
                    "country": "Germany", 
                    "state": "Saxony", 
                    "zip": "01307"
                }, 
                "name": "Department of Anesthesiology and Intensive Care, University Hospital Carl Gustav Carus"
            }, 
            "investigator": {
                "last_name": "Marcelo Gama de Abreu, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Variable Tidal Volumes During Open Abdominal Surgery on Lung Function and Systemic Inflammation", 
        "overall_contact": {
            "email": "mgabreu@uniklinikum-dresden.de", 
            "last_name": "Marcelo Gama de Abreu, MD, PhD", 
            "phone": "+493514584488"
        }, 
        "overall_contact_backup": {
            "email": "peter.spieth@uniklinikum-dresden.de", 
            "last_name": "Peter M Spieth, MD", 
            "phone": "+4935145816006"
        }, 
        "overall_official": {
            "affiliation": "Klinikum Ludwigshafen", 
            "last_name": "Marcelo Gama de Abreu, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "description": "Forced vital capacity is assessed on the first postoperative day", 
            "measure": "Forced vital capacity", 
            "safety_issue": "No", 
            "time_frame": "Preoperative until 5th postoperative day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01683578"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "PacO2 on the first postoperative day", 
                "measure": "Arterial partial CO2 pressure", 
                "safety_issue": "No", 
                "time_frame": "Preoperative until 5th postoperative day"
            }, 
            {
                "measure": "Peak expiratory flow", 
                "safety_issue": "No", 
                "time_frame": "Preoperative until 5th postoperative day"
            }, 
            {
                "description": "Forced expiratory volume after 1 sec (FEV1) on first postoperative day", 
                "measure": "Forced expiratory volume after 1 sec", 
                "safety_issue": "No", 
                "time_frame": "Preoperative until 5th postoperative day"
            }, 
            {
                "description": "PaO2/FIO2 during the intraoperative period", 
                "measure": "PaO2/FIO2", 
                "safety_issue": "No", 
                "time_frame": "Preoperative until 5th postoperative day"
            }, 
            {
                "description": "Distribution of ventilation in lungs", 
                "measure": "Distribution of ventilation", 
                "safety_issue": "No", 
                "time_frame": "Preoperative until 5th postoperative day"
            }, 
            {
                "description": "Amount of lung atelectasis on the first postoperative day", 
                "measure": "Atelectasis", 
                "safety_issue": "Yes", 
                "time_frame": "Preoperative until 5th postoperative day"
            }, 
            {
                "description": "Development of postoperative pulmonary complications", 
                "measure": "Postoperative pulmonary complications", 
                "safety_issue": "No", 
                "time_frame": "Preoperative until discharge from hospital"
            }, 
            {
                "description": "Concentrations of interleukine(IL)-6, IL-8 and tumor necrosis factor(TNF)-alpha in plasma", 
                "measure": "Inflammation markers", 
                "safety_issue": "No", 
                "time_frame": "Preoperative until 5th postoperative day"
            }
        ], 
        "source": "Technische Universit\u00e4t Dresden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t Dresden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}